Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus

NCT01494987 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

431

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Ranolazine
DRUG: Placebo
DRUG: Glimepiride
BEHAVIORAL: Diet
BEHAVIORAL: Exercise

Sponsor

Gilead Sciences